FDAnews
www.fdanews.com/articles/86672-viragen-announces-research-collaboration-with-prominent-biodefense-consultant-to-u-s

VIRAGEN ANNOUNCES RESEARCH COLLABORATION WITH PROMINENT BIODEFENSE CONSULTANT TO U.S.

May 9, 2006

Viragen, Inc. today announced that the Company has entered into a research collaboration agreement with AFG BioSolutions, Inc., a prominent biodefense consultant to the U.S. federal government. Maryland-based AFG BioSolutions has agreed to conduct in vivo research studies using Multiferon (natural, human alpha interferon) to evaluate its utility as a broad-acting anti-viral agent against a variety of biological threats such as smallpox and other biowarfare viral threat agents.
Yahoo News